Development of Fully Redispersible Dried Nanocrystals by Using Sucrose Laurate as Stabilizer for Increasing Surface Area and Dissolution Rate of Poorly Water-Soluble Drugs-Reference-Cited by-同舟云学术

Development of Fully Redispersible Dried Nanocrystals by Using Sucrose Laurate as Stabilizer for Increasing Surface Area and Dissolution Rate of Poorly Water-Soluble Drugs

Published:2021-10 Issue: Volume: Page:
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Prajapati Hetal,Serajuddin Abu T.M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. Liu R Introduction. Water-Insoluble Drug Formulation. 2. Boca Raton: CRC Press; 2018:1–5.

2. IV-IVC considerations in the development of immediate-release oral dosage form;Li;J Pharm Sci,2005

3. Integrated drug product development – from lead candidate selection to life-cycle management;Puddipedi,2019

4. Nanosizing: a formulation approach for poorly-water-soluble compounds;Merisko-Liversidge;Eur J Pharm Sci,2003

5. Nanocrystal technology, drug delivery and clinical applications;Junghanns;Int J Nanomed,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Dissolution, Solid-state Properties, and Long-term Storage Stability of Cryoprotectant-free Fenbendazole Nanoparticles;AAPS PharmSciTech;2024-08-28

2. QbD-based formulation development of resveratrol nanocrystal incorporated into soluble mesoporous material: Pharmacokinetic proof of concept study;International Journal of Pharmaceutics;2024-08

3. Recent developments in the use of nanocrystals to improve bioavailability of APIs;WIREs Nanomedicine and Nanobiotechnology;2024-03

4. Withdrawn: Probucol will Become a New Model for Treating Cerebral Infarction with a High Risk of Hemorrhage;Current Medicinal Chemistry;2024-01-04

5. Design of Redispersible High-Drug-Load Amorphous Formulations: Impact of Ionic vs Nonionic Surfactants on Processing and Performance;Molecular Pharmaceutics;2023-10-25